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Background: One of the best-characterized causative factors of Alzheimer’s disease (AD) is the generation of
amyloid-β peptide (Aβ). AD subjects are at high risk of epileptic seizures accompanied by aberrant neuronal
excitability, which in itself enhances Aβ generation. However, the molecular linkage between epileptic seizures and
Aβ generation in AD remains unclear.
Results: X11 and X11-like (X11L) gene knockout mice suffered from epileptic seizures, along with a malfunction of
hyperpolarization-activated cyclic nucleotide gated (HCN) channels. Genetic ablation of HCN1 in mice and HCN1
channel blockage in cultured Neuro2a (N2a) cells enhanced Aβ generation. Interestingly, HCN1 levels dramatically
decreased in the temporal lobe of cynomolgus monkeys (Macaca fascicularis) during aging and were significantly
diminished in the temporal lobe of sporadic AD patients.
Conclusion: Because HCN1 associates with amyloid-β precursor protein (APP) and X11/X11L in the brain, genetic
deficiency of X11/X11L may induce aberrant HCN1 distribution along with epilepsy. Moreover, the reduction in
HCN1 levels in aged primates may contribute to augmented Aβ generation. Taken together, HCN1 is proposed to
play an important role in the molecular linkage between epileptic seizures and Aβ generation, and in the
aggravation of sporadic AD.Background
Alzheimer's disease (AD) is characterized by progressive
memory impairment, which accompanies aging. Genetic
and biochemical studies show that the production of
amyloid-β peptide (Aβ) largely contributes to the etiology
of AD [1]. Aβ is generated from amyloid-β precursor pro-
tein (APP) by β- and γ-cleavage of the latter.
The risk of seizure activity is particularly high in AD
patients, with an 87-fold increase in subjects with early-
onset dementia compared with an age-matched refer-
ence population [2-7]. Factors linking seizure activity to
Aβ generation in AD patients remain unclear, although
epilepsy is believed to result from abnormal regulation* Correspondence: tsuzuki@pharm.hokudai.ac.jp
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reproduction in any medium, provided the orof neuronal excitability, which favors hypersynchrony. In
addition, increased neuronal activity enhances Aβ pro-
duction from APP [8-10].
Hyperpolarization-activated cyclic nucleotide gated HCN
channels 1–4 (HCN1–4) conduct inward, depolarizing
mixed Na+/K+ currents and thereby control resting mem-
brane potential, dendritic integration, synaptic transmis-
sion, and rhythmic activity in cardiac pacemaker cells
and spontaneous firing neurons [11]. Dysregulation of
these channels and their hyperpolarization-activated (Ih)
currents is strongly implicated in various experimental
animal models of epilepsy, as well as in human epilepsy
patients [12]. Furthermore, HCN2 co-assembles with the
X11-like (X11L) protein [13], which is a metabolic regula-
tor of APP processing [14].
X11 proteins (X11s) comprise a family of three evolu-
tionarily conserved molecules (X11/X11α/Mint1, X11L/d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bind to the cytoplasmic region of APP in cultured cells
and suppress its metabolism [15,16]. Moreover, the me-
tabolism of overexpressed human APP (hAPP) is sup-
pressed in X11 and X11L transgenic mice, along with the
generation of Aβ [17-19]. On the other hand, mutant mice
lacking X11L (X11+/+/X11L-/- mice) or both X11 and
X11L (X11-/-/X11L-/- mice) facilitate amyloidogenic metab-
olism of endogenous murine APP and exogenous hAPP,
including Aβ generation [20-22]. Therefore, inactivation of
X11/X11L clearly increases the production of Aβ, poten-
tially contributing to the pathology of AD.
Here, we report that i) X11-/-/X11L-/- mice suffer from
spontaneous epileptic seizures along with malfunction of
HCN channel activity; ii) HCN1 can form a complex with
APP and X11 or X11L in the murine brain; iii) HCN1-/-
gene knockout mice show enhanced Aβ generation;
iv) overexpression of HCN1 in Neuro2a (N2a) cells
decreases Aβ generation, whereas blockage of HCN1
channel activity in N2a cells restores the level of Aβ pro-
duction; v) the level of HCN1 diminishes significantly in
the temporal cortex of cynomolgus monkeys (Macaca
fascicularis) during aging; and vi) HCN1 levels are signifi-
cantly reduced in the brains of sporadic AD patients com-
pared with the brains of age-matched healthy subjects.Figure 1 Electrocorticogram recording and histological changes assoc
electrocorticogram recorded in 13-week-old X11-/-/X11L-/- mice (n = 4). Epi
(d, e, f) immunoreactivity in the hippocampus of X11+/+/X11L+/+ (a, d) and
and at 90 min after an epileptic episode (c, f). Scale bar, 200 μm.Given the previous reports and our current observa-
tions, we hypothesize that X11 and X11L play an import-
ant role in the modulation of HCN channel function, the
dysregulation of which correlates with epilepsy. We fur-
ther hypothesize that the impairment of HCN channels,
and in particular HCN1, accompanies with the aberrant
production of Aβ, which manifests as neurotoxicity. Thus,
HCN1 together with X11 and X11L may provide a mo-
lecular link between seizure activity and Aβ generation in
AD patients.
Results
Spontaneous epileptic seizures caused by X11 and X11L
gene deficiency
Electrocorticograms were recorded in X11+/+/X11L+/+
(wild type), X11+/+/X11L-/-, X11-/-/X11L+/+, and X11-/-/
X11L-/- mice. We found that X11-/-/X11L-/- mice suffered
from spontaneous epileptic seizures at the age of 13 weeks
and over (detailed results are provided in Additional file 1:
Figure S1 and Additional file 2: Movies S1, Additional
file 3: Movies S2 and Additional file 4: Movies S3). Three
out of four X11-/-/X11L-/- mice showed an abnormal elec-
trocorticogram recording within 48 h, namely, the pres-
ence of epileptic discharge, which were never observed
in X11+/+/X11L+/+, X11+/+/X11L-/-, or X11-/-/X11L+/+iated with epileptic seizures in X11-/-/X11L-/- mice. (A) An
leptic discharges are underlined. (B) c-Fos (a, b, c) and Egr-1/zif268
X11-/-/X11L-/- (b, c, e, f) mice under steady-state conditions (a, b, d, e)
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file 4: Movie S3). Subsets of X11-/-/X11L-/- mice went into
status epilepticus and died.
Seizures are often associated with the augmented ex-
pression of immediate-early genes in neurons [23]. We
first asked whether such gene activation was observed in
X11-/-/X11L-/- mice following epileptic seizures and inves-
tigated the involvement of specific brain regions in seizure
activity. Brain tissue sections from X11-/-/X11L-/- mice‘
Figure 2 Expression of X11 and X11L in the 13-week-old mouse brain
X11+/+/X11L+/+ mice were stained for X11 (C, F, I, L) and X11L (B, E, H, K).
IgG followed by donkey anti-mouse IgG conjugated to Alexa Fluor 488, an
conjugated to Cy3. Merged images are shown in the left panels (A, D, G, J)
300 μm (A–C), 50 μm (D–L).were immunostained for c-Fos, a calcium-dependent im-
mediate-early gene product, and Egr-1/Zif268, an early
growth response transcription factor, within 90 min of
a seizure event. The brains of these mice showed
enhanced expression of both c-Fos and Egr-1/Zif268 in
the dentate gyrus (DG) granule cells compared with the
brains of X11+/+/X11L+/+ and X11-/-/X11L-/- mice
(Figure 1B). However, we cannot rule out a possibility that
subclinical discharges without aberrant behavior may. Representative images of horizontal brain sections from 13-week-old
Immunohistochemistry was performed with anti-X11 polyclonal rabbit
d anti-X11L monoclonal mouse IgG followed by donkey anti-rabbit IgG
. Blue signals indicate nuclei counter-stained with DAPI. Scale bars,
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Thus, a deficiency in both X11 and X11L may cause
abnormal, seizure-associated neuronal activity and subse-
quent alterations in protein expression in the hippocampal
formation.
Reduction of Ih currents in entorhinal cortex (EC) layer II
of X11-/-/X11L-/- mice
Spontaneous epileptic seizures were observed in mice
when both X11 and X11L genes were deficient (Figure 1A,
Additional file 1: Figure S1 and additional movies). Because
the DG granule cells of X11-/-/X11L-/- mice showed aug-
mented expression of c-Fos and Egr-1/Zif268 following
seizure activity, we next performed a detailed examination
of the expression of both proteins in hippocampal neurons
in 13-week-old murine brains (Figure 2).
Distinct expression patterns of X11 and X11L were
observed in the hippocampus of wild type mice. X11L
was expressed mainly in the pyramidal neurons of the
CA1–3 region (Figure 2B, E, H), whereas X11 was
expressed in other types of interneurons (Figure 2C, F, I).
These observations coincide with our previous report of
X11s expression in aged wild type mice [21]. Unlike c-Fos
and Egr-1/Zif268 in the double mutant mouse, X11 and
X11L were not expressed in DG granule cells (Figure 2D–F).
However, both X11 and X11L were strongly co-
expressed in EC layer II (Figure 2J–L), which projects
axons primarily to the granule cells of the DG [24].
Furthermore, both HCN1 and HCN2 are expressed in
EC layer II [25]. Given that HCN1-/- mice show
enhanced seizure susceptibility and that HCN2-/- mice
suffer from absence seizures [26,27], we next focused
our investigations on the alteration of Ih currents asso-
ciated with HCN channels in EC layer II in X11-/-/
X11L-/- mice.
Horizontal brain slices that included the EC and the
hippocampus were prepared from 12–14-week-old
X11+/+/X11L+/+, X11+/+/X11L-/-, X11-/-/X11L+/+, and
X11-/-/X11L-/- mice. EC layer II neurons were then sub-
jected to electrophysiological analysis, and Ih currents from
HCN channels were recorded (Figure 3 and Additional
file 1: Figure S2). The mice used in the electrophysiological
study were seizure-naïve, at least without over behavioral
manifestations, and showed comparable levels of HCN1
channels in the EC (Additional file 1: Figure S3). Simi-
lar to a previous report [28], hyperpolarizing voltage
steps activated a large Ih current in EC layer II cells of
X11+/+/X11L+/+ mice (Figure 3A and C). By contrast, the
Ih current was dramatically reduced in X11-/-/X11L-/-
mice relative to that in X11+/+/X11L+/+ mice (Figure 3B
and D); however, no significant alterations were observed
for the V1/2 (mean ± SEM, X11+/+/X11L+/+: −81.1±1.1
mV; X11-/-/X11L+/+: −80.3±1.3 mV; X11+/+/X11L-/-:
−83.5±1.4 mV; X11-/-/X11L-/-: −81.3±0.9 mV) (Figure 3E) orthe series resistance (mean ± SEM, X11+/+/X11L+/+: 8.3±0.2
MΩ; X11-/-/X11L+/+: 8.9±0.5 MΩ; X11+/+/X11L-/-: 9.2±0.4
MΩ; X11-/-/X11L-/-: 8.0±0.2 MΩ) (Figure 3F). Quantitative
analysis (Figure 3G) revealed that the density of the Ih
current was also significantly reduced in X11-/-/X11L-/- mice
(1.12±0.15 pA/pF, n = 9; p < 0.01) compared with that in
X11+/+/X11L+/+ mice (2.18±0.27 pA/pF, n = 10), but did not
change significantly in X11-/-/X11L+/+ mice (2.41±0.25
pA/pF, n = 9, p > 0.05) or in X11+/+/X11L-/- mice (2.05±0.29
pA/pF, n = 9, p > 0.05). Thus, genetic ablation of X11 and
X11L together had a profound impact on the Ih current in
the EC layer II of the double knockout mice. These results
correlate with the observation that X11-/-/X11L-/- mice, but
not X11+/+/X11L+/+, X11+/+/X11L-/-, or X11-/-/X11L+/+ mice,
are susceptible to spontaneous epileptic seizures.
In EC layer II, the dominant HCN subtype is HCN1
[28]. We found that HCN1, X11, and X11L were coloca-
lized in EC layer II neurons (Figure 3H) and apparently
formed a complex in the brain (Figure 3I–K). The colo-
calization of these molecules was observed in a region
surrounding the neuronal nucleus (Figure 3H), consist-
ent with the location of the Golgi apparatus. Because
X11 and X11L are largely localized in the Golgi appar-
atus and function in the trafficking of membrane pro-
teins [29,30], the deletion of X11 and X11L may disturb
intracellular localization of HCN channels (Additional
file 1: Figure S4). While the localization of the channel
likely affects its function, we cannot rule out the possi-
bility that X11 and X11L directly regulate HCN1 func-
tion as well.
Enhanced Aβ generation according to HCN1 dysfunction
The EC is one of the most vulnerable brain regions in
AD [31], and it is well-known that synaptic activity such
as that mediated by HCN channels can regulate Aβ gen-
eration [8-10]. Therefore, we examined whether HCN
channel impairment involved in the aberrant production
of Aβ. We first quantified the levels of endogenous
Aβ40 and Aβ42 in HCN1-/- mouse brains. Aβ40 and
Aβ42 were both significantly increased in the cortex of
HCN1-/- mice compared with HCN1+/+ mice (average ±
SEM, Aβ40: n = 5, p = 0.0037; Aβ42: n = 5, p = 0.0055)
(Figure 4A). The magnitude of the increase in Aβ40 and
Aβ42 was inversely proportional to the level of HCN1
gene expression (Figure 4A, left panel), while APP pro-
tein levels were comparable in HCN1+/+, HCN1+/-, and
HCN1-/- mice (Figure 4A, right panel).
To confirm whether the increase in Aβ generation in
HCN1-/- mice depends on the decrease in HCN channel
activity, we used N2a cells that transiently overexpressed
FLAG-APP and HCN1 (Figure 4B). Overexpression of
HCN1 significantly reduced the generation of Aβ40 and
Aβ42 (compare column 2 with column 3 for each Aβ pep-
tide). The Aβ levels were restored by adding ZD7288, a
Figure 3 Reduction of Ih currents in entorhinal cortex layer II neurons of X11-/-/X11L-/- mice. (A, B) Representative electrophysiological
recordings of Ih currents from EC layer II neurons in X11+/+/X11L+/+ (A) and X11-/-/X11L-/- (B) mice. (C, D) Tail currents of X11+/+/X11L+/+ (C) and
X11-/-/X11L-/- (D) mice. (E) Quantitative data of the voltage, whereby the current is half-activated (V1/2). Statistical analysis was performed using
one-way analysis of variance followed by Tukey’s multiple comparison test (mean ± SEM (mV); five slices from two X11+/+/X11L+/+ mice,
n = 10; four slices from two X11-/-/X11L+/+, X11+/+/X11L-/-, and X11-/-/X11L-/- mice, n = 9). (F) Quantitative data of series resistance. Statistical
analysis was performed as described (mean ± SEM (MΩ); five slices from two X11+/+/X11L+/+ mice, n = 10; four slices from two X11-/-/X11L+/+,
X11+/+/X11L-/-, and X11-/-/X11L-/- mice, n = 9). (G) Summary of the current density of the tail currents. Statistical analysis was performed as
described (mean ± SEM (pA/pF); five slices from two X11+/+/X11L+/+ mice, n = 10; four slices from two X11-/-/X11L+/+, X11+/+/X11L-/-, and X11-/-/
X11L-/- mice, n = 9; **p < 0.01). (H) Representative images of the HCN1-X11-X11L complex in EC layer II neurons of 13-week-old X11+/+/X11L+/+
mice (a, merge; b HCN1 (green); c, X11L (red); d, X11(blue)). Scale bar, 20 μm. (I−K) Co-immunoprecipitation of HCN1-X11s complexes from the
13-week-old X11+/+/X11L+/+ murine cortex. HCN1-/- (I), X11-/- (J), or X11L-/- (K) mice were used as controls. Brain lysates were immunoprecipitated
with anti-HCN1 (I), anti-X11 (J), and anti-X11L/Mint2 (K) antibodies. Immunocomplexes were detected by immunoblotting.
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Figure 4 Functional deficits in the HCN1 channel facilitate Aβ generation. (A) Quantification of endogenous murine Aβ40 and Aβ42 in the
cortex of 4-month-old HCN1+/+, HCN1+/-, and HCN1-/- mice by using the sELISA system (left panels). Statistical analysis was performed using the
two-tailed Mann–Whitney U-test (average ± SEM, n = 5, **p < 0.01). (B) Quantification of Aβ40 and Aβ42 secreted into the culture medium by
N2a cells by using the sELISA system. FLAG-APP or FLAG-APP and HCN1 were transiently overexpressed in the cells with (+) or without (−) 10 μM
ZD7288 (left panels). Statistical analysis was performed using one-way analysis of variance followed by Tukey’s multiple comparison test (average
± SEM, n = 4, ***p < 0.001). Expression levels of APP and HCN1 was confirmed by immunoblotting (right panels in A and B).
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3 through 6). Although we have not confirmed the block-
age of channel activity electrophysiologically, ZD7288 had
no effect on Aβ levels in cells without HCN1 expression
(column 5), and APP expression was not affected by either
the presence of HCN1 or by the administration of
ZD7288 (Figure 4B, right panel). Furthermore, administra-
tion of ZD7288 did not influence the interaction of HCN1
with APP (Additional file 1: Figure S5). These results
suggest that the suppression of Aβ generation in HCN1-
overexpressing cells probably depends on channel activity
(Figure 4B), in agreement with the in vivo observation that
the brains of mice lacking the HCN1 gene and with
impaired HCN channel activity (Figure 3B, D, and G)
demonstrated increased Aβ generation (Figure 4A).
Association of HCN1 with APP in vivo and in vitro
Increased synaptic activity enhances Aβ generation [8-10],
and modulation of Aβ generation is not limited toalterations in HCN1 channel activity. Indeed, APP metab-
olism is thought to be largely regulated by APP-binding
partners [14]. Therefore, we next explored the hypothesis
that HCN1 might be involved in regulating APP metabol-
ism via a physical interaction between the channel and
APP. In support of this hypothesis, an anti-HCN1 anti-
body co-immunoprecipitated APP together with HCN1
from a lysate of wild type murine cortex (Figure 5A). The
interaction seemed to be specific in that APP was not
recovered from the cortical lysate of HCN1-/- mice. The
association between APP and HCN1 was next confirmed
in the EC. Using EC-rich brain samples isolated from
HCN1+/+ and HCN1-/- mice (Additional file 1: Figure
S3A), a co-immunoprecipitation assay was performed
with an anti-HCN1 antibody, and the immunoprecipitates
were analyzed with the indicated antibodies (Figure 5B).
Along with X11 and X11L, APP was co-immunoprecipitated
with HCN1 in EC-rich brain samples of wild type mice
(Figure 5B), suggesting that HCN1 can complex with
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ment with the co-localization results of HCN1, X11, and
X11L in the wild type cortex shown above (Figure 3H–K).
Tubulin and PSD95 (postsynaptic density protein 95)
were not detected in the immunocomplex, indicatingFigure 5 (See legend on next page.)the specific association of APP and X11/X11L with
HCN1.
To show whether HCN1 directly binds to APP without
mediation by X11/X11L, FLAG-APP and HCN1 were tran-
siently expressed in N2a cells and a co-immunoprecipitation
(See figure on previous page.)
Figure 5 APP and HCN1 form a molecular complex in vivo and in vitro. (A) Co-immunoprecipitation of the HCN1-APP complex from the
wild type and HCN1-/-murine cortex. Brain lysates were immunoprecipitated with an anti-HCN1 antibody. Immunocomplexes were detected by
immunoblotting. (B) Co-immunoprecipitation of HCN1-APP, -X11 and -X11L complexes from the EC-rich cortex (see Additional file 1: Figure S2).
Brain lysates were immunoprecipitated with an anti-HCN1 antibody. Immunocomplexes were detected by immunoblotting. (C–G) Co-
immunoprecipitation of the HCN1-APP complex from N2a cells transiently overexpressing FLAG-APP and murine HCN1. (C–E), Analysis of
FLAG-APP and murine HCN1, (F) C99-FLAG and murine HCN1, and (G) APPFL or APPΔcyt and murine HCN1 immunocomplexes. To standardize the
amount of plasmid, empty vector (−) was added to yield 1.2 μg of plasmid in total. Cell lysates were immunoprecipitated with anti-FLAG M2
(C and F), anti-APP extracellular domain (LN27) (D), or anti-HCN1 (E and G) antibodies. Immunocomplexes were detected by immunoblotting.
(H) Affinity purification of FLAG-sAPP secreted into the culture medium by N2a cells expressing FLAG-APP. The purification was performed using
anti-FLAG M2 affinity beads. FLAG-sAPP were specifically detected by M2 and anti-APP extracellular domain (LN27) antibodies, and no
contaminating bands were identified by CBB-staining. (I) Pull-down of HCN1 with affinity purified FLAG-sAPP prepared in (H). Lysates from wild
type cells (−) and cells that transiently expressed HCN1 (+) were incubated with M2 affinity beads coupled with FLAG-tag or FLAG-sAPP. The
complexes resulting from the pull-down assay were subjected to immunoblot analysis with anti-HCN1 antibody.
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noprecipitated HCN1 along with FLAG-APP (Figure 5C).
An anti-hAPP extracellular domain antibody (LN27) also
recovered HCN1 (Figure 5D), and anti-HCN1 antibody
recovered FLAG-APP (Figure 5E).
APP is a type I transmembrane protein composed of a
large extracellular (luminal) domain of 596 amino acids
and a small intracellular domain of 47 amino acids. On
the other hand, HCN1 is six-transmembrane protein
with short extracellular sequences between transmem-
brane regions one and two, three and four, and five and
six; and long intracellular domains within the amino-
and carboxyl-terminal regions of the protein. To deter-
mine the region of APP that binds to HCN1, we per-
formed co-immunoprecipitation assays using APP
deletion mutants (C99-FLAG, which largely lacks the
extracellular domain of APP and in which FLAG is fused
to the carboxyl terminal region of APP; and APPΔcyt,
which lacks the 43- amino acid carboxyl terminal region
of APP) (Figure 5F, G). The results of this assay
indicated that HCN1 was not co-immunoprecipitated
with C99-FLAG (Figure 5F), whereas APPΔcyt was co-
immunoprecipitated with HCN1 (Figure 5G).
Next, we performed an in vitro pull-down assay with
FLAG-soluble APP (FLAG-sAPP, consisting of the extra-
cellular domain of APP cleaved at the α- and/or β-cleavage
sites). FLAG-sAPP was purified with affinity beads (anti-
FLAG M2 affinity gel) from the culture medium of N2a
cells expressing FLAG-APP (Figure 5H) and then incu-
bated with lysates of N2a cells that expressed HCN1.
HCN1 bound to FLAG-sAPP, but not to FLAG-tag alone
(Figure 5I). Taken together, the results shown in Figure 5
indicate that HCN1 associates with APP through its extra-
cellular (luminal) domain.
Hence, HCN1 apparently interacts with the extracellular
domain of APP (Figure 5) and with both X11 and X11L in
the cytoplasm (Figure 3H–K, Figure 5B). This suggests
that the HCN1 channel might form a ternary complex
with APP and either X11 or X11L to regulate Aβgeneration. However, the detailed molecular regulation of
complex formation remains to be determined.
Age- and AD state-dependent HCN disruption in the
temporal cortex (superior temporal gyrus) of cynomolgus
monkeys and sporadic AD patients
Advanced age is the greatest risk factor for AD. To
examine the relationship between aging and HCN1
levels, we quantified the amount of HCN1, Aβ, APP, and
actin in freshly frozen brain tissues (superior temporal
gyrus) from cynomolgus monkeys of various ages
(Figure 6A and Additional file 1: Figure S6). Senile pla-
ques and neurofibrillary tangles spontaneously appear in
the brains of cynomolgus monkeys with advancing age
[32,33], and the amino acid sequence of Aβ in cynomol-
gus monkeys is identical to that in humans [34]. Thus,
we hypothesized that the cynomolgus monkey would
be a useful animal model for the investigating the rela-
tionship between aging and AD pathology. Significant
negative correlations were found between HCN1 levels
and age (n = 39, r = −0.5363, p = 0.0004) (Figure 6A, left),
between HCN1 and APP levels (n = 39, r = −0.3796,
p = 0.0086) (Additional file 1: Figure S6B), between HCN1
and TBS-insoluble Aβ40 levels (n = 39, r = −0.2878,
p = 0.0421) (Additional file 1: Figure S6C and D), and
between HCN1 and Tris buffered saline (TBS)-insoluble
Aβ42 levels (n = 39, r = −0.2913, p = 0.0401) (Additional
file 1: Figure S6E and F). A significant positive correlation
was found between age and APP level (n = 39, r = 0.8156,
p < 0.0001) (Additional file 1: Figure S6A), and a signifi-
cant weak-positive correlation was found between APP
and TBS-insoluble Aβ42 levels (n = 39, r = 0.3714, p = 0.0236)
(Additional file 1: Figure S6H). However, no correlation
was found between age and actin level (n = 39, r = −0.1981,
p = 0.2266) (Figure 6A, right) or between APP and
TBS-insoluble Aβ40 levels (n = 39, r = 0.2993, p = 0.072)
(Additional file 1: Figure S6G).
Finally, we examined the possibility of altered HCN1
levels in human AD brain specimens obtained at autopsy
Figure 6 HCN1 levels decrease in a age- and AD-dependent
manner. (A) Quantification of the amount of HCN1 and actin in the
brain (superior temporal gyrus) of 4–37-year-old cynomolgus
monkeys by immunoblotting. Statistical analysis was performed
using the two-tailed Pearson's correlation coefficient (HCN1: n = 39,
r = −0.5363, ***p < 0.001; actin: n = 39, r = −0.1981, p > 0.05).
(B) Quantification of the amount of HCN1, APP, actin, and tubulin in
age-matched AD and non-AD postmortem brains (superior temporal
gyrus) by immunoblotting. Statistical analysis was performed using
the two-tailed Mann–Whitney U-test (non-AD: n = 13, AD: n = 12,
**p < 0.01). (C) Comparison of postmortem time between non-AD
and AD samples. Statistical analysis was performed using the two-
tailed Mann–Whitney U-test (non-AD: n = 13, AD: n = 12,
p = 0.8066). The correlation between postmortem time and HCN1
level was analyzed. Statistical analysis was performed using the
two-tailed Pearson's correlation coefficient (n = 39, r = −0.2416,
p = 0.2446). Descriptions of all subjects are provided in Table 1.
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significantly different for the AD and non-AD brain
samples used in this study (non-AD: n = 13, AD: n = 12,
p = 0.8066), and no significant decrease in HCN1 levels
related to postmortem time was observed (n = 25,
r = −0.2416, p = 0.2446) (Figure 6C and Table 1). Of great
relevance to this study, the amount of HCN1 was signifi-
cantly reduced in AD brains (superior temporal gyrus)
compared with that in age-matched control brains (non-
AD: n = 13, AD: n = 12, p = 0.0083), while the levels of
APP and actin were not significantly altered (Figure 6B
and Table 1). These results suggest that the reduction in
HCN1 expression that occurs with age (Figure 6A) may be
involved in the aggravation of the pathology of AD.
Discussion
X11 and X11L are well-characterized neural adaptor
proteins that regulate the trafficking and metabolism of
APP [14]. Many reports indicate that X11s bind to APP
and suppress Aβ generation in vitro and in vivo [14-22].
Furthermore, X11s are thought to mediate a number of
cellular functions through their association with various
proteins [35]. This report showed that mutant mice lacking
both X11 and X11L present with dysfunctional HCN1
channel activity and epileptic seizures. Notably, AD patients
are also at increased risk of epileptic seizures. Furthermore,
mutant mice lacking HCN1 demonstrated increased gener-
ation of Aβ, which is a causative factor for the development
of AD.
The incidence of AD dramatically increases with age.
We found that the amount of HCN1 decreased with
both aging and in AD. The dysfunction of HCN1 that
occurs over time may, thus, be a trigger for epileptic
seizures and the pathogenic generation of Aβ in AD.
Several converging studies corroborate the premise that
HCN channel activity is closely related to epileptogenesis
[11]. For example, HCN1 expression is significantly
reduced in the EC after temporal lobe epilepsy [36,37].
Furthermore, HCN1 channel plasticity in cortical neurons
is similar in multiple epileptic animal models [38-43].
Moreover, kainic acid-induced seizure susceptibility is
increased in HCN1-/- mice [27], and HCN2-deficient mice
exhibit spontaneous absence seizures [26].
HCN1-/- mice show a significantly higher number of
negative resting membrane potentials and a significantly
higher input resistance measured from responses to ei-
ther negative or positive current steps [28]. As such,
seizure susceptibility is increased in HCN1-/- mice [27],
indicating that loss of the HCN1 subunit enhances
neuronal excitability, which can increase Aβ generation
[8-10]. These observations suggest that enhanced Aβ
generation in HCN1-/- mice results from neuronal
hyper-excitability, which is in turn caused by ablation
of the HCN1 gene.
Table 1 Summary of subject information presented in Figure 6B and C
Sample
no.






Seizure Relative ratio (protein/tubulin)
Actin APP HCN1
1 Normal 84 F 877 1 - 0.929 1.192 0.809
2 Normal 88 F 144 1 - 0.856 1.046 0.859
3 Normal 70 M 340 0.5 - 0.955 1.189 0.859
4 AD 84 M 71 4 - 0.950 1.171 0.952
5 AD 70 M 276 4 - 0.829 0.986 0.716
6 AD 74 M 322 5 - 0.961 0.990 0.827
7 AD 75 M 594 6 - 1.069 1.176 0.589
8 AD 76 M 947 6 + 1.190 1.167 0.273
9 AD 79 F 203 5 - 1.019 0.913 0.317
10 AD 81 M 360 6 - 0.971 0.862 0.247
11 AD 81 F 442 5 - 0.971 0.862 0.385
12 AD 82 F 254 6 - 0.988 1.029 0.313
13 AD 82 F 533 5 - 0.988 1.001 0.566
14 AD 82 F 338 4 - 1.028 1.063 0.770
15 AD 84 M 590 5 - 1.071 1.128 0.876
16 Normal 78 F 87 2 - 1.108 1.138 2.153
17 Normal 81 M 134 1 - 1.122 0.971 0.902
18 Normal 82 F 148 1 - 1.178 1.109 1.963
19 Normal 82 F 155 2 - 1.141 1.026 0.821
20 Normal 80 M 317 2 - 1.254 1.037 0.893
21 Normal 80 M 510 2 - 1.071 0.778 0.669
22 Normal 82 M 530 1 - 0.979 0.916 0.384
23 Normal 78 M 575 1 - 0.905 1.007 0.713
24 Normal 78 M 690 1 - 0.784 0.986 1.479
25 Normal 82 M 736 1 - 0.774 0.743 1.448
Postmortem brain samples were obtained from the Brain Bank for Aging Research, Tokyo Metropolitan Institute of Gerontology. Experimental procedures were
approved by the appropriate ethical boards at each institute. Autopsies were performed with written informed consent from the patients or their relatives. The
clinical diagnosis of AD was based on two major criteria: the Diagnostic and Statistical Manual of Mental Disorders: 4th Edition (DSM-IV) and the National Institute
of Neurological and Communicational Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA). The neuropathological
diagnosis of AD was made using Consortium to Establish a Registry for Alzheimer’s Disease criteria (average age at death, 79.2 ± 4.4 years). Control brains were
obtained from age-matched individuals with no history of neurological or psychiatric illness (average age at death, 80.4 ± 4.2 years). Subjects, age, gender,
postmortem time, Braak stage, seizure history, and relative protein/tubulin ratios are indicated.
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HCN1 physically associated with APP through the extra-
cellular domain of APP. Therefore, HCN1-mediated
regulation of Aβ generation may depend on a molecular
linkage between HCN1 and APP and not simply on
alterations in neuronal excitability. However, the mo-
lecular mechanism by which HCN1 potentially links
epileptic seizures to Aβ generation in AD remains to be
elucidated.
Our results suggest that ablation of X11/X11L induces
aberrant HCN1 distribution and function along with epi-
lepsy. Although the molecular mechanism by which
X11s regulates HCN channel activity also remains
unclear, X11s are known to modulate intracellulartrafficking of membrane proteins. For example, X11s
interact with certain proteins implicated in traffic and
transport, such as Arfs, Rab6, and KIF17 [29,44,45]. Fur-
thermore, X11s bind to vesicular cargo proteins, such as
APP and alcadein [16,46,47] and regulate the intracellu-
lar distribution of APP [21,30]. We hypothesize that X11
and X11L similarly influence the trafficking and/or intra-
cellular localization of HCN1. We further hypothesize
that the mislocalization of HCN1 observed in X11-/-/
X11L-/- mice (Additional file 1: Figure S4) may cause
aberrant excitatory neuronal activities, resulting in epi-
leptic seizures.
In conclusion, this study indicates that HCN1 may
play an important role in the regulation of neuronal
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formation. However, we cannot rule out the possibility
that additional ion channels (e.g., M-channels, Kir-channels,
and sodium leak channels) also participate in the regulation
of APP metabolism. Taken together, the current observa-
tions may provide new insights into the mechanisms
underlying the linkage between epileptic seizures and Aβ
generation in AD.
Methods
Animals and human non-AD and AD brain samples
All animal studies were conducted in compliance with
the guidelines of the Animal Studies Committees of
Hokkaido University (Sapporo, Japan), Shiga University
(Shiga, Japan), and the National Institute of Biomedical
Innovation (Osaka, Japan). Mice were maintained under
a 12-h light/12-h dark cycle (lights on, 7:00 A.M.–7:00
P.M.), and provided with food and water ad libitum.
X11-/-/X11L+/+, X11+/+/X11L-/-, and X11-/-/X11L-/- mice
have already been described [20,21]. HCN-/- mice (stock
number 005034) were purchased from The Jackson
Laboratory (Bar Harbor, Maine). Male mice were used
for all experiments.
Brain samples containing the superior temporal gyrus
of cynomolgus monkeys (Macaca fascicularis) were
obtained from Shiga University of Medical Science and
the National Institute of Biomedical Innovation. The mon-
keys were housed in individual cages prior to the experi-
ment and were maintained according to institutional
guidelines for experimental animal welfare. Human brain
samples containing the superior temporal gyrus (Broadmann
area 22) were obtained from the Brain Bank for Aging
Research, the Tokyo Metropolitan Institute of Gerontology
(Itabashi, Tokyo, Japan). Human temporal cortical specimens
for the quantification of proteins were obtained from brains
that were removed, processed, and stored at −80°C within
16 h postmortem at the Brain Bank at Tokyo Metropolitan
Institute of Gerontology. (Patients were placed in a cold
(4°C) room within 2 h of death.) For all brains registered
at the bank, written informed consent for their use for
medical research was obtained from the patient prior to
death or from the patient's family. Brain specimens were
collected from Broadmann area 22 (superior temporal
gyrus) for 12 AD patients (79.2±4.4 years of age) and 13
control patients (80.4±4.2 years of age) [48]. Detailed
descriptions of all subjects, including the relative protein/
tubulin ratio for each individual, are shown in Table 1.
Antibodies
Polyclonal rabbit anti-HCN1 antibody [25] and poly-
clonal rabbit anti-X11 UT153 antibody [21] have already
been described. Monoclonal mouse anti-tubulin DM1A
antibody and polyclonal rabbit anti-c-Fos, rabbit anti-
Egr-1, and goat anti-HCN1 antibodies (sc-19706) werepurchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Characterization and demonstration of the
antigen-specificity of the goat anti-HCN1 antibody
(sc-19706) is shown in Additional file 1: Figure S7.
Monoclonal mouse anti-X11L/mint2 and anti-PSD95
antibodies were purchased from BD Transduction Labora-
tories (Lexington, KY, USA). Anti-actin antibody and
the anti-HCN1 antibody, AB5884, were purchased from
Millipore (Billerica, MA, USA). Anti-FLAG M2 and poly-
clonal rabbit anti-APP cytoplasmic domain (N-terminus)
antibodies were purchased from Sigma-Aldrich (St. Louis,
MO, USA), and the anti-human APP extracellular domain
antibody (LN27) was purchased from Zymed (San
Francisco, CA, USA). Anti-FLAG M2 affinity gel and
FLAG peptide were purchased from Sigma-Aldrich.
Plasmid construction
Human APP695 (hAPP695) and FLAG-APP695 cDNA
were inserted into the pcDNA3 plasmid at the HindIII/
XbaI restriction sites to produce pcDNA3-hAPP695 and
pcDNA3-FLAG-hAPP695 [46]. The cDNA constructs
pcDNA3-hAPPΔcyt (in which amino acids 652–695 of
hAPP695 are deleted) and pcDNA3.1-C99-FLAG (in
which the signal sequence of hAPP is inserted into the 5’
region of C99) were generated by PCR using pcDNA3-
hAPP695 as the template. The generated fragments were
ligated into pcDNA3-hAPP695 and pcDNA3.1-FLAG at
the BamHI/XbaI restriction site and the HindIII/XbaI
restriction site, respectively. The pCI-murine HCN1 vec-
tor was a kind gift from Dr. Takahiro M. Ishii [49].
Immunohistochemistry
Murine brain tissue sections were prepared and incu-
bated with primary antibodies as described [21]. The
sections were further incubated with goat anti-rabbit
IgG antibodies conjugated to biotin (Vector Laboratories,
Burlingame, CA, USA), followed by the ABC complex.
Peroxidase activity was revealed using diaminobenzidine
as the chromogen. Alternatively, sections were incubated
with donkey anti-mouse IgG coupled with Alexa Fluor
488, donkey anti-rabbit IgG coupled with Cy3, or donkey
anti-goat IgG coupled with Alexa Fluor 633 in phosphate
buffered saline (PBS) containing 3% bovine serum albumin
(BSA) for 2 h at room temperature. Sections were
mounted onto slides with Shandon Immu-Mount (Thermo,
Pittsburgh, PA, USA) and viewed under a BZ-9000 micro-
scope (Keyence, Woodcliff Lake, NJ, USA).
Immunoblotting and co-immunoprecipitation analysis
The cortices of wild type, X11-/-/X11L+/+, X11+/+/X11L-/-,
X11-/-/X11L-/-, HCN1+/-, and HCN1-/- mice, and cyno-
molgus monkey brains (superior temporal gyrus) and
human post-mortem brains (superior temporal gyrus)
were homogenized in eight volumes of radioimmune
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dodecyl sulfate (SDS) and a protease inhibitor mixture
(5 μg/ml chymostatin, 5 μg/ml leupeptin, and 5 μg/ml
pepstatin). The homogenates were lysed by sonication
on ice and centrifuged at 20,000 × g for 10 min at 4°C.
The resulting supernatants were used for immunoblot ana-
lysis. Proteins (10 μg per lysate) were separated via SDS
(w/v) polyacrylamide gel electrophoresis (SDS-PAGE) on
7.5% (w/v) polyacrylamide gels.
The cortex (from one mouse) and EC-rich region
(from five mice) from wild type and gene-null mice were
homogenized in eight volumes of HBS-T lysis buffer
(10 mM HEPES [pH 7.6] containing 150 mM NaCl, 5 mM
EDTA, 0.5% [v/v] Triton X-100, 5 μg/ml chymostatin,
5 μg/ml leupeptin, and 5 μg/ml pepstatin A). Homogenates
were then centrifuged at 20,000 × g for 10 min at 4°C. N2a
cells (~1 × 106) were transiently transfected with 0.8 μg
pcDNA3-FLAG-hAPP695, pcDNA3-hAPP695, pcDNA3-
hAPPΔcyt, or pcDNA3.1-C99-FLAG and 0.4 μg of
pCI-murine HCN1 using Lipofectamine 2000 (Invitrogen)
and cultured for 24 h in medium (DMEM) containing
10% (v/v) fetal bovine serum (FBS). Cells were har-
vested, lysed in lysis buffer (PBS containing 1.0% [v/v]
Triton X-100, 5 μg/ml chymostatin, 5 μg/ml leupeptin,
and 5 μg/ml pepstatin A), and centrifuged for 5 min at 4°C.
The resulting supernatants were incubated with anti-
FLAG M2, anti-hAPP extracellular domain (LN27), anti-
HCN1, anti-X11, or anti-X11L/Mint2 antibody at 4°C for
2 h. Each immunocomplex was recovered with Dyna-
beadsW Protein G (Invitrogen) and washed three times with
lysis buffer. The proteins were separated on 7.5% (w/v)
polyacrylamide gels, transferred onto nitrocellulose mem-
branes, and analyzed by immunoblotting with the indi-
cated antibodies. The immunoreactants were detected
using the ECL plus™ detection system (GE Healthcare,
Houston, TX, USA) and quantified using a Versa Doc
model 3000 (Bio-Rad, Hercules, CA, USA).
Affinity purification of FLAG-sAPP from N2a conditioned
medium and immunoprecipitation of APP-HCN1 complex
N2a cells (~8.8 × 106) were transiently transfected with
5 μg pcDNA3-FLAG-hAPP695 using Lipofectamine 2000
(Invitrogen) and cultured for 24 h in 8 mL of medium
(DMEM) containing 10% (v/v) FBS. FLAG-sAPP was col-
lected from the conditioned culture medium by using
50 μL of anti-FLAG M2 affinity gel. The collected FLAG-
sAPP that was bound to the gel was washed twice with
wash buffer I (20 mM Tris–HCl [pH 8.0], 1 M NaCl, and
0.1% Triton X-100) and twice with wash buffer II (50 mM
Tris–HCl [pH8.0], 150 mM NaCl, 1% Triton X-100, 0.05%
SDS, and 5 mM EDTA). Collected FLAG-sAPP was then
eluted from the affinity gel with 20 μg FLAG-peptide and
subjected to immunoblotting and Coomassie brilliant blue
(CBB) staining to ascertain the degree of purification.FLAG-sAPP or FLAG-peptide coupled to anti-FLAG
M2 affinity beads were then incubated for 2 h at 4°C
with HBS-T-soluble lysates derived from wild type N2a
cells or N2a cells transiently overexpressing HCN1. The
beads were washed three times with HBS-T lysis buffer.
The proteins bound to the beads were separated on 7.5%
(w/v) polyacrylamide gels, transferred onto membranes,
and analyzed by immunoblotting with the indicated anti-
bodies. The immunoreactants were detected using the
ECL plus™ detection system (GE Healthcare) and quanti-
fied using a Versa Doc model 3000 (Bio-Rad).
Quantification of Aβ40 and Aβ42
Endogenous murine Aβ was measured as described pre-
viously [21] using cortices dissected from 4-month-old
mice. Murine Aβ40 and Aβ42 were measured using a
sandwich ELISA (sELISA) system (mouse/rat Aβ40 and
Aβ42 assay kit, Immuno-Biological Laboratories (IBL),
Fujioka, Japan). N2a cells (~2 × 105) were transiently
transfected with 0.2 μg pcDNA3-FLAG-hAPP695 and
0.1 μg pCI-murine HCN1 using Lipofectamine 2000
(Invitrogen) and cultured in medium (DMEM) contain-
ing 10% (v/v) FBS. After 24 h, cells were incubated in
fresh medium for an additional 4 h with or without 10 μM
ZD7288 (Tocris Bioscience, Bristol, UK). Human Aβ40
(hAβ40) and hAβ42 secreted into the culture medium
during the 4-h incubation were quantified using the
sELISA system.
Electroencephalogram recording
To obtain free-moving cortical electrocorticogram record-
ings, recording and reference electrodes were screwed onto
the skull over the temporal (anterior = −3.1 mm, lateral =
2.5 mm, relative to bregma) and occipital regions of the
murine brain. Recordings were continuously made using a
cortical electroencephalogram linked to a telemetry sys-
tem (Unimec, Usmate Velate, Italy) throughout the experi-
ment [50].
Ih current recording
All experiments were performed in a blinded manner.
Mice (12–14 weeks old) were anesthetized with halo-
thane (Takeda Chemical Industries) and then sacrificed
by decapitation. The brain was rapidly removed and im-
mediately placed in a cold (4°C) cutting solution, which
contained 234 mM sucrose, 2.5 mM KCl, 1.1 mM
NaH2PO4, 10 mM MgSO4, 26 mM NaHCO3, 12 mM
glucose, and 0.5 mM CaCl2. Horizontal slices (300 μm
thick), which included the EC and the hippocampus, were
prepared using a vibratome (VT1000S, Leica, Nussloch,
Germany). During recording, individual slices were trans-
ferred to a submerged recording chamber and continu-
ously perfused with artificial cerebrospinal fluid (ACSF)
maintained at 30–32°C. The ACSF contained 125 mM
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26 mM NaHCO3, 12 mM glucose, and 2.0 mM CaCl2 and
was saturated with 95% O2 and 5% CO2. Whole-cell
patch-clamp recordings were obtained from principal ex-
citatory cells in layer II of the EC. The patch pipettes were
filled with an intracellular solution containing 30 mM
K-methanesulfonate, 6 mM NaCl, 0.2 mM EGTA, 10 mM
HEPES, 4 mM Mg-ATP, 0.3 mM Na3-GTP, and 10 mM
phosphocreatine-Tris (pH 7.3). In layer II cells of the EC,
the hyperpolarization-induced and “slowly-activating” in-
ward currents in the voltage-clamp mode mainly con-
sisted of Ih currents [51]. When Ih currents were studied
in the voltage-clamp mode, membrane potentials were
first held at −65 mV, and then voltage steps with a dur-
ation of 7 s were applied from −55 mV to −125 mV
(10 mV increments), after which the holding potentials
were allowed to return to −65 mV to obtain the tail cur-
rents. The amplitudes of the tail currents at 50 ms after
the end of the final voltage step were analyzed to obtain
the Ih currents. In all electrophysiological analyses,
pooled data were represented as the mean ± SEM.
Statistical analysis
Statistical analyses were performed using a two-tailed
Mann–Whitney U-test, a one-way analysis of variance
followed by Tukey’s multiple comparison test, or the
two-tailed Pearson's correlation coefficient. All analyses
were conducted with GraphPad Prism 5 software.
Additional files
Additional file 1: Figure S1. Simultaneous recording of
electrocorticogram in epilepsy model mice and corresponding movie. A
representative electrocorticogram recorded during the interictal period in
13-week-old X11-/-/ X11L-/- mice (n = 4) is shown. The underlined region
indicates the time frame of the corresponding movie (Movie S3).
Figure S2. Individual data of Ih currents density in entorhinal cortex layer
II neurons of wild-type and X11s-null mice. (A) Indicidual data of Ih
current density. Blue indicate the data of mouse #1 and red indicate
mouse #2. (B) Mean, SD, SEM, and count number of A. P Value of
Student’s t-test (#1 vs #2) shown in bottom line. (C) Distribution and
average of current density of A. Closed symbols indicate the data of
mouse #1 and opened symbols indicate mouse #2 (mean ± SEM).
Figure S3. HCN1 levels in the EC-rich region of the brains of X11+/+/X11L
+/+ and X11s mutant mice. (A) Isolation of the EC-rich region from a
horizontal slice (300 μm thick) of murine brain. Brain slices from 13-week-
old X11+/+/X11L+/+, X11+/+/X11L-/-, X11-/-/X11L+/+, and X11-/-/X11L-/- mice
were prepared in ice-cold PBS using a vibratome (VT1200S; Leica)
(left panel). The EC-rich region (EC) was separated from each slice as
indicated (right panel). (B, C) Quantification of HCN1 in the EC-rich
region. Horizontal slices were homogenized in eight volumes of
radioimmune precipitation assay buffer containing 0.5% (w/v) SDS and a
protease inhibitor mixture (5 μg/ml chymostatin, 5 μg/ml leupeptin, and
5 μg/ml pepstatin), subjected to sonication on ice, and centrifuged at
20,000 × g for 10 min at 4°C. (B) The resulting supernatants (each
containing 10 μg protein) were analyzed by SDS-PAGE on 7.5% (w/v)
polyacrylamide gels, followed by immunoblotting with anti-HCN1, anti-
X11, anti-X11L, and anti-tubulin antibodies (n = 4). (C) The HCN1 level
was normalized to the tubulin level to give the relative HCN1/tubulin
ratio for each genotype (mean ± SEM, n = 4). Figure S4. Altereddistribution of the HCN channel in X11-/-/X11L-/- mice. (A) Low-power
images of horizontal brain sections from 13-week-old wild type
(X11+/+/X11L+/+: upper panels) and X11-/-/X11L-/- (Lower panels) mutant
mice were immunostained with an anti-HCN1 antibody (n=3). Scale bar,
300 μm. (B) Representative high-resolution images of horizontal brain
sections from 13-week-old X11+/+/X11L+/+ (a, c) and X11-/-/X11L-/- (b, d)
mice were subjected to immunostaining with an anti-HCN1 antibody
(a, b) and Nissl stain (c, d). (C) Quantitative analysis of HCN1
immunoreactivity in the EC of 13-week-old wild type (X11+/+/X11L+/+)
and X11-/-/X11L-/- mutant mice. The intensity of the HCN1
immunoreactivity in the areas enclosed by the open boxes in A was
measured using NIH Image J software. Scale bar, 50 μm.
Figure S5. Complex formation of HCN1 with APP in N2a cells treated
with ZD7288. FLAG-APP and HCN1 were transiently overexpressed in N2a
cells (~1 × 106) with (+) or without (−) 10 μM ZD7288. To standardize the
amount of plasmid transfected into the cells, an empty vector (−) was
added to yield 1.2 μg of plasmid in total. The cell lysates were subjected
to immunoprecipitation with anti-FLAG M2 antibody. Immunocomplexes
were detected by immunoblotting with anti-HCN1 and anti-FLAG
antibodies. Figure S6. Covariance analysis of various protein levels in the
brain of cynomolgus monkeys. (A–H) Levels of HCN1, APP, Aβ40, and
Aβ42 in the brain (superior temporal gyrus) of 4–37-year-old cynomolgus
monkeys were quantified by immunoblotting and sELISA assay. Protein
levels were normalized to tubulin levels or to tissue weight to give the
relative protein/tubulin ratio for immunoblotting and the relative protein/
tissue weight ratio for sELISA. (A) Correlation between age and APP level
(n = 39, r = 0.8156, ****p < 0.0001). (B) Correlation between HCN1 and
APP levels (n = 39, r = −0.3796, **p = 0.0086). (C, D) Correlation between
HCN1 and Aβ40 levels (n = 39, r = −0.2878, *p = 0.0421). An enlarged
view of (C) in the 0 to 1,000 f mol/mg tissue range is shown in (D)
(E, F) Correlation between HCN1 and Aβ42 levels (n = 39, r = −0.2913,
*p = 0.0401). An enlarged view of (E) in the 0 to 400 f mol/mg tissue
range is shown in (F). (G) Correlation between APP and Aβ40 (n = 39,
r = 0.2993, p = 0.072). (H) Correlation between APP and Aβ42 levels
(n = 39, r = 0.3714, *p = 0.0236). Statistical analysis was performed using
the two-tailed Pearson's correlation coefficient. Figure S7. Specificity of
the polyclonal goat anti-HCN1 antibody. (A) Competition analysis using
glutathione-S-transferase (GST) fused to the 60-amino acid carboxyl
terminal region of murine HCN1 (mHCN1 C60). This region of the protein
contains the epitope for the goat anti-HCN1 antibody used in this study
(sc-19706: Santa Cruz Biotechnology). Brain lysates (10 μg protein)
derived from HCN1+/+ and HCN1-/- mice and cynomolgus monkeys were
subjected to immunoblot analysis. The anti-HCN1 antibody was pre-
incubated with 20 μg GST alone or GST-mHCN1 C60 recombinant
protein at 4oC for 2 h. The pre-incubated antibody was then reacted with
the immunoblots. HCN1 was detected in HCN1+/+ mouse and monkey
brains when the antibody was pre-incubated with GST alone, but not
when the antibody was pre-incubated with GST-mHCN1 C60. (B) Titer
comparison between anti-HCN1 antibodies. Brain lysates (10 μg protein)
were subjected to immunoblot analysis with two commercial anti-HCN1
antibodies (sc-19706, Santa Cruz Biotechnology; and AB5884, Millipore).
(C) Specificity of goat anti-HCN1 antibody (sc-19706) for
immunohistochemical analysis. (a, b) Representative images of
horizontal brain sections showing the hippocampal formation in
13-week-old HCN1+/+ (a) and HCN1-/- (b) mice stained with goat anti-
HCN1 antibody, followed by donkey anti-goat IgG coupled with FITC.
(c, d) Magnified view of the squares in (a) and (b). HCN1 signals (green)
observed in HCN1+/+ mice were absent in HCN1-/- mice. Nuclei
counter-stained with DAPI are shown in blue. Scale bars, 300 μm (a, b),
50 μm (c, d).
Additional file 2: Movie S1. Spontaneous epileptic seizures in X11-/-/
X11L-/- mice. The electrocorticogram of Supplementary Figure S1 and
Movie S3 were simultaneously recorded.
Additional file 3: Movie S2. Spontaneous epileptic seizures in X11-/-/
X11L-/- mice. The electrocorticogram of Supplementary Figure S1 and
Movie S3 were simultaneously recorded.
Additional file 4: Movie S3. Spontaneous epileptic seizures in X11-/-/
X11L-/- mice. The electrocorticogram of Supplementary Figure S1 and
Movie S3 were simultaneously recorded.
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